Arcus Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-12.9M | $-17.0M | $4.1M | $90.0K |
| FY2017 | $-25.1M | $-30.6M | $5.5M | $495.0K |
| FY2018 | $-43.0M | $-46.7M | $3.7M | $3.9M |
| FY2019 | $-73.5M | $-75.4M | $1.9M | $9.0M |
| FY2020 | $111.0M | $108.0M | $3.0M | $22.0M |
| FY2021 | $-256.0M | $-282.0M | $26.0M | $55.0M |
| FY2022 | $438.0M | $432.0M | $6.0M | $65.0M |
| FY2023 | $-306.0M | $-330.0M | $24.0M | $73.0M |
| FY2024 | $-170.0M | $-176.0M | $6.0M | $76.0M |
| FY2025 | $-482.0M | $-484.0M | $2.0M | $60.0M |